Stent with dual support structure

• US 6,132,461 A
• Filed: 04/29/1998
• Issued: 10/17/2000
• Est. Priority Date: 03/27/1998
• Status: Expired due to Term

• Current Assignee: Ev3 Peripheral Inc. (Medtronic Plc)
• Original Assignee: Intratherapeutics Incorporated (Sulzer Medica)
• Inventors: Thompson, Paul J.
• Primary Examiner(s): Snow, Bruce
• Application Number:
  US09/069,347
• Time in Patent Office: 902 Days
• Field of Search: 623/1.12, 606/108, 606/192, 606/194
• US Class Current: 623/1.15
• CPC Class Codes: A61F 2/86 Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/91508 the meander having a difference in amplitude along the band
• CPC Class Codes: A61F 2002/91525 within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
• CPC Class Codes: A61F 2002/91541 Adjacent bands are arranged out of phase
• CPC Class Codes: A61F 2002/91558 connected peak to peak
• CPC Class Codes: A61F 2002/91566 connected trough to trough
• CPC Class Codes: A61F 2230/0013 Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
• CPC Class Codes: A61F 2230/0054 V-shaped
• CPC Class Codes: A61F 2250/001 for adjusting a diameter

Abstract

A intraluminal stent comprises a reticulated tube having an un-deployed diameter and expandable to an enlarge diameter. The tube includes a structural beam extending between first and second ends. The structural beam changes from a first geometry to a second geometry when the tube changes from the un-deployed diameter to the enlarged diameter. The structural beam includes first and second longitudinal elements each extending at least partially between the first and second ends and with a spacing between the first and second elements. Each of said first and second elements changes from the first geometry to the second geometry when the tube changes from the un-deployed diameter to the enlarged diameter for the spacing to remain substantially unchanged as the tube changes from the un-deployed diameter to the enlarged diameter.

Claims

1. An intraluminal stent comprising:

a stent body expandable from an un-deployed orientation to a deployed orientation;

the stent body having cell defining portions with opposing surfaces defining an open cell bounded by the cell defining portion, the cell having a major axis (X_M) and a minor axis (X_m);

each cell defining portion including a first longitudinal segment and a second longitudinal segment, the first and second longitudinal segments connected at first and second ends, each of the first and second longitudinal segments comprising;

(a) first and second spaced-apart longitudinal elements having a spacing therebetween;

(b) a longitudinal axis (X_a), the longitudinal axis (X_a) for the first longitudinal segment positioned parallel to and on a first side of the cell major axis (X_M), and the longitudinal axis (X_a) for the second longitudinal segment positioned parallel to and on a second opposite side of the cell major axis (X_M);

(c) an undulating pattern comprising a plurality of peaks spaced outwardly from and a plurality of valleys spaced inwardly from the longitudinal axes (X_a), the spacing extending at least partially along the undulating pattern between the first and second ends;

the first and second longitudinal segments being configured such that the spacing between the first and second spaced-apart longitudinal elements remains substantially unchanged as the stent body is expanded from the un-deployed orientation to the deployed orientation.

2. An intraluminal stent according to claim 1 wherein the first and second spaced-apart longitudinal elements are mutually parallel both before and after expanding the stent body from the un-deployed orientation to the deployed orientation.

3. An intraluminal stent according to claim 1 wherein the first and second spaced-apart longitudinal elements are substantially uniformly spaced-apart.

4. An intraluminal stent according to claim 1 wherein the cell defining portion is symmetrical about both the major axis and the minor axis.

5. An intraluminal stent according to claim 1 wherein the first and second spaced-apart longitudinal elements and the spacing therebetween each extend substantially between the first and second ends.

6. An intraluminal stent according to claim 1 wherein the stent body further comprises:

a first longitudinal connection location at the first end for connection of the cell to a first longitudinally adjacent cell, the first longitudinal connection location positioned on the major axis,

a second longitudinal connection location at the second end for connection of the cell to a second longitudinally adjacent cell, the second longitudinal connection location positioned on the major axis,

a first transverse connection location for connection of the cell to a first transversely adjacent cell, the first transverse connection location positioned on the minor axis, and

a second transverse connection location for connection of the cell to a second transversely adjacent cell, the second transverse connection location positioned on the minor axis.

7. An intraluminal stent according to claim 6, wherein the cell is substantially identical to each of the first longitudinally adjacent cell, the second longitudinally adjacent cell, the first transversely adjacent cell, and the second transversely adjacent cell.

8. An intraluminal stent according to claim 6, the cell having:

an un-deployed length, measured along the major axis between the first longitudinal connection location and the second longitudinal connection location when the stent body is in the un-deployed orientation, and

a deployed length, measured along the major axis between the first longitudinal connection location and the second longitudinal connection location when the stent body is in the deployed orientation,

wherein the deployed length is greater than the un-deployed length.

9. An intraluminal stent according to claim 6, the cell having:

an un-deployed width, measured along the minor axis between the first transverse connection location and the second transverse connection location when the stent body is in the un-deployed orientation, and

a deployed width, measured along the minor axis between the first transverse connection location and the second transverse connection location when the stent body is in the deployed orientation,

wherein the deployed width is substantially equal to the un-deployed width.

10. An intraluminal stent according to claim 6, wherein each of the first and second longitudinally adjacent cells and the first and second transversely adjacent cells has a major axis and a minor axis;

(a) the major axis of the cell is linearly aligned with the major axes of the first and second longitudinally adjacent cells;

(b) the minor axis of the cell is linearly aligned with the minor axes of the first and second transversely adjacent cells.